{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T02:47:35Z","timestamp":1776566855857,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ejca.2003.11.026","type":"journal-article","created":{"date-parts":[[2004,2,6]],"date-time":"2004-02-06T05:17:37Z","timestamp":1076044657000},"page":"696-700","source":"Crossref","is-referenced-by-count":27,"title":["Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"F.Y.F.L.","family":"de Vos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.B.","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.J.","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Messerschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.M.","family":"Burgerhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2003.11.026_BIB1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-111-1-22","article-title":"Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group","volume":"111","author":"Williams","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejca.2003.11.026_BIB2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.1994.12.4.701","article-title":"Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin","volume":"12","author":"Williams","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide","volume":"316","author":"Williams","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2003.11.026_BIB4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1200\/JCO.1990.8.4.715","article-title":"Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin","volume":"8","author":"Gershenson","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.1994.12.2.378","article-title":"Cisplatin-based chemotherapy for ovarian germ cell malignancies","volume":"12","author":"Segelov","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7326\/0003-4819-116-9-709","article-title":"Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer","volume":"116","author":"Gietema","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejca.2003.11.026_BIB8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","article-title":"Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2003.11.026_BIB9","doi-asserted-by":"crossref","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.ejca.2003.11.026_BIB10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-200104000-00013","article-title":"Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin","volume":"23","author":"Gelevert","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejca.2003.11.026_BIB11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejca.2003.11.026_BIB12","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/1097-0258(20000830)19:16<2101::AID-SIM523>3.0.CO;2-G","article-title":"Estimating disease prevalence from two-phase surveys with non-response at the second phase","volume":"19","author":"Gao","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejca.2003.11.026_BIB13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB14","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0305-7372(02)00038-5","article-title":"The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures","volume":"28","author":"Nuver","year":"2002","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejca.2003.11.026_BIB16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(05)71326-X","article-title":"Syndrome X in testicular-cancer survivors","volume":"357","author":"Gietema","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2003.11.026_BIB17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejca.2003.11.026_BIB18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000227478","article-title":"Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer","volume":"52","author":"Fossa","year":"1995","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2003.11.026_BIB19","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.82.11.3783","article-title":"Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects","volume":"82","author":"Rosolova","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejca.2003.11.026_BIB20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0895-4356(94)00200-A","article-title":"Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness","volume":"48","author":"Ma","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB21","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.1999.17.9.2670","article-title":"Outcome and reproductive function after chemotherapy for ovarian dysgerminoma","volume":"17","author":"Brewer","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2001.19.4.1015","article-title":"Survival and reproductive function after treatment of malignant germ cell ovarian tumors","volume":"19","author":"Zanetta","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/hq1201.100241","article-title":"Estrogen replacement and brachial artery flow-mediated vasodilation in older women","volume":"21","author":"Herrington","year":"2001","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB24","doi-asserted-by":"crossref","first-page":"12E","DOI":"10.1016\/S0002-9149(02)02405-0","article-title":"Protective effects of estrogen on the cardiovascular system","volume":"89","author":"Mendelsohn","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejca.2003.11.026_BIB25","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.161.16.2000","article-title":"Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria","volume":"161","author":"Monster","year":"2001","journal-title":"Arch. Intern. Med."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980490400005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980490400005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:54:19Z","timestamp":1550192059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980490400005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S095980490400005X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2003.11.026","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}